SEC Form 4 · accession 0001144204-16-093743
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric I Richman
Director
Period of report
Apr 7, 2016
Accepted (ET)
Apr 11, 2016 · 6:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Apr 7, 2016 | M | 5,367 | $1.76 | A | 182,189 | D | |
| Common Stock, $0.0001 par value per share | Apr 7, 2016 | S | 5,367 | $2.20 | D | 176,822 | D | |
| Common Stock, $0.0001 par value per share | Apr 8, 2016 | M | 6,400 | $1.76 | A | 183,222 | D | |
| Common Stock, $0.0001 par value per share | Apr 8, 2016 | S | 6,400 | $2.20 | D | 176,822 | D | |
| Common Stock, $0.0001 par value per shareF2 | holding | — | — | — | 10,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.76 | Apr 7, 2016 | M | 5,367 | D | Sep 30, 2012 | Sep 30, 2021 | Common Stock | 5,367 | 19,633 | D |
| Employee Stock Option (right to buy) | $1.76 | Apr 8, 2016 | M | 6,400 | D | Sep 30, 2012 | Sep 30, 2021 | Common Stock | 6,400 | 13,233 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2015.
- F2Held indirectly as previously reported on Form 4 dated November 10, 2011.